In 2004 European and American regulators approved the first microarray-based medical test.
2004年，欧洲与美国的权威批准了首例给予微数组技术的医学检验。
2
At the forefront of developing such microarray-based diagnostics is Roche, which has several cancer tests in clinical development based on the AmpliChip platform.
研发这类芯片的前沿在罗氏公司，他们已经急于amplichip平台开发了上面所提到的诊断方法。
3
The amount of information generated by a microarray-based experiment is sufficiently large that no single study can be expected to mine each nugget of scientific information.